Page 98 - Multidisciplinary Approach to Managing Bone Health in Prostate Cancer - Update 2019
P. 98
PCWG3 Criteria to Define Progression on Bone Scans
• ≥ 2 new lesions on bone scan
• Recommended assessment interval:
– Metastatic prostate cancer: Every 8 to 9 weeks for the first six
months and every 12 weeks thereafter
– Nonmetastatic CRPC: Every 16 weeks
– Long-term responders (>2 to 3 years of clinical benefit and no signs
of clinical or biomarker progression):
16 to 24 weeks
1. Scher HI, et al. J Clin Oncol 2016;34:1402-18
